Dr. Adina Elena Stanciu is a researcher with a diverse academic background and a strong focus on cancer-related research. She earned her MSc from the University of Bucharest in 1992 and subsequently completed her Ph.D. at the same university, focusing on the impact of gamma radiation on biomolecular systems. Since 2008, she has been a principal investigator in the Department of Carcinogenesis and Molecular Biology at the Institute of Oncology "Prof. Dr. Alex. Trestioreanu" Bucharest. Dr. Stanciu's research interests encompass various areas, including matrix pathobiology, cell signaling, and molecular targeting, with a particular emphasis on tumor-selective radiopharmaceutical targeting. Her work also delves into the role of metalloproteinases in tissue organization, pathogenesis, and the advancement of various disorders, notably cancer and heart disease. Dr. Stanciu holds the Head of the Carcinogenesis and Molecular Biology Department position at the Institute of Oncology "Prof. Dr. Alex Trestioreanu" Bucharest.